Horizon Technology Finance Corp (NASDAQ: HRZN)

Horizon Technology Finance Corporation is a specialty finance company that lends to and invests in development-stage companies in the technology life science healthcare information and services and sustainability industries. The company provides secured debt investments known as Venture Loans to venture capital and private equity backed companies as well as publicly traded companies in its target industries. Horizon Technology Finance Corporation operates as an externally managed closed-end non-diversified management investment company and has elected to be regulated as a business development company under the Investment Company Act of 1940 and to be treated as a regulated investment company for U. S. federal income tax purposes. The company's investment objective is to maximize total return by generating current income from debt investments and capital appreciation from warrants received in connection with those investments.

Horizon Technology Finance Corporation generates revenue primarily through interest income from its debt investment portfolio and fee income from success fees prepayment fees and other charges related to its lending activities. The company earns interest from secured term loans made to portfolio companies in its target industries and receives additional income from the accretion of origination fees and end of term payments. Revenue also comes from warrants and equity received in settlement of interest and fee income as well as prepayment fees generated when portfolio companies repay debt before maturity. The company's revenue is derived from its investment activities rather than from the sale of products or services to end consumers.

Horizon Technology Finance Corporation does not report operational segments based on business lines or product categories.

Horizon Technology Finance Corporation operates within the specialty finance and business development company sector where it competes with other BDCs and venture debt providers. The company maintains a competitive position through its focus on secured first lien debt investments in high growth industries and its ability to provide financing after venture capital or equity investments have been made in portfolio companies. Its competitive advantages include its specialized underwriting approach for development-stage companies its externally managed structure and its tax-efficient status as a regulated investment company which allows it to avoid corporate-level income taxes on distributed earnings.

Horizon Technology Finance Corporation serves venture capital and private equity backed companies as well as publicly traded companies in the technology life science healthcare information and services and sustainability industries. The company's portfolio includes investments in firms engaged in medical device manufacturing software development biotechnology diagnostics alternative energy and healthcare information systems. Specific customer names are not disclosed in the filing but the company's debt investments are made to portfolio companies operating across these targeted industry sectors.